WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 13'9901 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 26'2451 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 96  96  95  95  94  81  71  66 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years 23  22  22  22  21  23  25  25 
Female 15-49 years 25  25  25  25  25  22  17  15 

Number of reported cases

(Click for retrospective incidence data for Seychelles)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  13 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Seychelles)
Vaccine year result method % card seen                                                
BCG          99*  98  99  99  99*  98 
DTP1          96  99  99  98  99 
DTP3          97  99*  98  98  99*  99 
DTP4          97  94 
IPV1          99 
HepB_BD         
HepB3          97  99*  98  98  99* 
Hib3          97  99*  98  98  99* 
JapEnc         
MCV1          98  99*  97  98  99*  86 
MCV2          98  98  97  99  99* 
PCV1         
PCV3         
Pol3          97  99*  98  98  99*  99 
Rota1         
RotaC         
Rubella1          98  99*  97  98  99* 
TT2plus          99*  97  99*  99*  99* 
PAB         
VAD1         
YFV          99  99*  97  99*  99 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Seychelles)
BCG
ChartChart
  98  99  99  99  99  98 
DTP1
ChartChart
  99  99  98  99  99  99 
DTP3
ChartChart
  99  98  98  99  98  99 
HepB3
ChartChart
  99  99  99  99  98 
HepB_BD
ChartChart
 
Hib3
ChartChart
  99  98  98  99 
MCV1
ChartChart
  99  97  98  99  97  86 
MCV2
ChartChart
  98  97  99  99 
PCV3
ChartChart
 
Pol3
ChartChart
  99  98  98  99  98  99 
RotaC
ChartChart
 

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; 6 years; Yes
DT 6 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 3, 4, 5 months; Yes
HPV 10, 11 years; Yes adolescent girls
HepB_Adult Yes adults at risk
IPV 4 months; Yes
MMR 15 months; 6 years; Yes
OPV 3, 4, 5, 18 months; 6, 15 years; Yes
TT 15, 25 years; Yes school children, pregnant women and other adults
YF 1 year; adults; Yes and travellers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2017  2013-2017  2013-2017  2008-2012  2008-2012  2008-2012  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 16  16  16  16  16  16  16 

System performance

Total Nº districts in country number 15  15  16  16  16  16  16 
Nº districts with DTP3 coverage >=80% number 12  15  15    16    16 
% of districts with DTP3 coverage >=80% From 0 to 100% 80  100  94    100    100 
Nº districts with measles (MCV1) coverage >=95% number   16    16 
% of districts with MCV1 coverage >=95% From 0 to 100% 60  60  56    100    100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 97    60  48  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.